-
Psychedelic Research & Fed Funding Are Priorities, Nat Institute Of Mental Health Sets Guidelines & Research Goals
Monday, November 28, 2022 - 1:27pm | 512The National Institute of Mental Health (NIMH) named the types of psychedelics studies to which it would grant funds and further guidance for pre-clinical research and studies with young participants, reported Marijuana Moment. NIMH’s notice of information states...
-
Trevena's 30% Plunge, Explained
Tuesday, February 21, 2017 - 10:48am | 414Trevena Inc (NASDAQ: TRVN), a clinical-stage biopharmaceutical company that focuses on therapeutics that use an approach to target G protein coupled receptors (GPCRs), saw its shares plummet around 30 percent Tuesday morning despite a positive development in Phase 3 trials. Trevena announced...
-
Importance Of Phase 2 Trials
Monday, July 25, 2016 - 9:14am | 515Healthcare and pharmaceutical companies begin evaluating a drug they wish to sell to the public through a series of clinical trials. A Phase I trial consists of a company testing its drug or therapy on a small group of 20 to 100 healthy volunteers. Chiara Russo, a stock analyst for Cantor...